EUVIMEDEUVIMED entdecken
Crossref

Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis

Liuyu Hu, Yipei Gu, Ju Liang, Mengmeng Ning, Junli Yang, Yi Zhang, Hui Qu, Yaxi Yang, Ying Leng, Bing Zhou iD

Journal of Medicinal Chemistry · 09.03.2023 · 66 (5) · 3284-3300

DOI: 10.1021/acs.jmedchem.2c01669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 17.02.2023. Verfasst von Liuyu Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai, Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonalcoholic steatohepatitis (NASH) is a progressive stage of nonalcoholic fatty liver disease (NAFLD) and is characterized by steatosis, inflammation, hepatocyte ballooning, and fibrosis. While there are currently no approved therapies for NASH, the thyroid hormone receptor β (THR-β), primarily expressed in the liver, is emerging as an effective molecular target for the treatment of NASH. However, the adverse cardiac and bone effects mediated by thyroid hormone receptor α (THR-α) need to be minimized. Herein, we reported the discovery of a series of novel THR-β agonists featuring pyrrolo[3,2-b]pyridin-5-one skeletons based on structure-based drug design. Further optimization led to compound 15, which exhibited higher potency and selectivity for THR-β over THR-α compared to clinical drug MGL-3196. More significantly, an excellent liver-to-serum ratio of 93:1 was observed for compound 15. We believe that the high hepatic concentration of compound 15 may result in no cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHumansThyroid Hormone Receptors betaLiverInflammationLiver Cirrhosis

Substanzen

Thyroid Hormone Receptors beta

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
  • University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, P. R. China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.

ORCID-Profile: Bing Zhou

Förderung

  • Natural Science Foundation of Shanghai
  • Ministry of Science and Technology of the People's Republic of China
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China
  • State Key laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Zitieren

APA

Hu, L., Gu, Y., Liang, J., Ning, M., Yang, J., Zhang, Y., Qu, H., Yang, Y., Leng, Y., & Zhou, B. (2023). Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis. Journal of Medicinal Chemistry, 66(5), 3284-3300. https://doi.org/10.1021/acs.jmedchem.2c01669

Vancouver

Hu L, Gu Y, Liang J, Ning M, Yang J, Zhang Y, et al. Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis. Journal of Medicinal Chemistry. 2023;66(5):3284-3300. doi:10.1021/acs.jmedchem.2c01669

BibTeX
@article{Hu2023,
  author = {Hu, Liuyu and Gu, Yipei and Liang, Ju and Ning, Mengmeng and Yang, Junli and Zhang, Yi and Qu, Hui and Yang, Yaxi and Leng, Ying and Zhou, Bing},
  title = {Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {5},
  pages = {3284--3300},
  doi = {10.1021/acs.jmedchem.2c01669}
}
Kostenlos starten →